# Association of Fractional Anisotropy in White Matter Bundles with Plasma Biomarkers of Neurodegeneration and Glial Reactivity in Individuals with Cognitive Complaints without dementia

**Authors:** Patricio F. Riquelme, Isaias Mery, Sebastian Aguilera, Fernando Henriquez, Vicente Medel, Pamela C L. Ferreira, Bruna Bellaver, Thomas Karikari, Tharick A. Pascoal, Daniela Thumala, Cecilia Okuma, Patricia Lillo, J. Cesar Cardenas, Christian González-Billault, Felipe A. Court, Claudia Duran-Aniotz, Pamela Guevara, Andrea Slachevsky

PMC · DOI: 10.21203/rs.3.rs-8621977/v1 · Research Square · 2026-01-19

## TL;DR

This study links blood biomarkers of brain aging to early white matter changes in people with cognitive complaints but no dementia.

## Contribution

It shows specific associations between plasma biomarkers and white matter integrity in pre-dementia stages.

## Key findings

- Higher p-tau217 and GFAP levels correlate with reduced FA in periventricular tracts like the corpus callosum and fornix.
- NfL levels show reduced FA in callosal fibers, while some biomarkers correlate with increased FA in limbic-related bundles.
- Findings support blood biomarkers as indicators of early brain structural vulnerability in neurodegeneration.

## Abstract

Age-related cognitive decline is preceded by subtle neurochemical and structural brain alterations that remain insufficiently characterized, particularly in individuals with cognitive complaints but without dementia. Circulating plasma biomarkers reflecting amyloid pathology, tau phosphorylation, astroglial reactivity, and axonal injury have emerged as accessible indicators of early neurodegenerative processes; however, their relationship with early white matter microstructural changes remains unclear. In this study, we investigated associations between plasma Aβ42/Aβ40, phosphorylated tau 217 (p-tau217), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL), and white matter integrity assessed by fractional anisotropy (FA) derived from diffusion MRI.

We analyzed data from 135 community-dwelling older adults with cognitive complaints but without dementia, recruited through a population-based strategy. Diffusion MRI data were processed using deterministic and correlational tractography to identify white matter pathways in which FA was significantly associated with plasma biomarker levels, controlling for age and education. Anatomical labeling of implicated tracts was performed using probabilistic white matter atlases.

Higher plasma levels of p-tau217 and GFAP were consistently associated with reduced FA across multiple periventricular white matter tracts, including the corpus callosum, fornix, optic radiations, and posterior thalamic radiations—pathways known to be vulnerable in early cognitive impairment. NfL exhibited a similar but more spatially restricted pattern, primarily involving callosal fibers. In parallel, direct associations between plasma biomarker levels and increased FA were observed in limbic-related bundles such as the cingulum and fornix, suggesting regionally specific microstructural responses that may reflect early adaptive or remodeling processes.

Together, these findings demonstrate that plasma biomarkers of neurodegeneration and glial reactivity are closely linked to white matter microstructural alterations at pre-dementia stages. This study provides converging neurochemical and neuroanatomical evidence supporting the utility of blood-based biomarkers as indicators of early brain structural vulnerability and reinforces their translational relevance in the study of age-related neurodegenerative processes.

## Linked entities

- **Proteins:** GFAP (glial fibrillary acidic protein), NEFL (neurofilament light chain)
- **Diseases:** dementia (MONDO:0001627)

## Full-text entities

- **Genes:** NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** Cognitive Complaints (MESH:D003072), amyloid (MESH:C000718787), Neurodegeneration (MESH:D019636), dementia (MESH:D003704), axonal injury (MESH:D001480)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12869620/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12869620/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12869620/full.md

---
Source: https://tomesphere.com/paper/PMC12869620